The results indicate that Pin1 knockdown significantly alleviated hepatic steatosis, fibrosis and inflammation in MCD-induced NAFLD mice, improved glucose tolerance and alleviated insulin resistance in mice. This evidence concerns the gene PIN1 and metabolic dysfunction-associated steatotic liver disease.